Details for Patent: 8,642,012
✉ Email this page to a colleague
Which drugs does patent 8,642,012 protect, and when does it expire?
Patent 8,642,012 protects RAVICTI and is included in one NDA.
This patent has forty patent family members in seventeen countries.
Summary for Patent: 8,642,012
Title: | Methods of treatment using ammonia-scavenging drugs |
Abstract: | The invention provides a method for determining a dose and schedule and making dose adjustments of PBA prodrugs used to treat nitrogen retention states, or ammonia accumulation disorders, by measuring urinary excretion of phenylacetylglutamine and/or total urinary nitrogen. The invention provides methods to select an appropriate dosage of a PBA prodrug based on the patient's dietary protein intake, or based on previous treatments administered to the patient. The methods are applicable to selecting or modifying a dosing regimen for a subject receiving an orally administered ammonia scavenging drug. |
Inventor(s): | Scharschmidt; Bruce (South San Francisco, CA) |
Assignee: | Hyperion Therapeutics, Inc. (South San Francisco, CA) |
Application Number: | 12/350,111 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,642,012 |
Patent Claim Types: see list of patent claims | Use; | More… ↓ |
Drugs Protected by US Patent 8,642,012
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Horizon Therap Us | RAVICTI | glycerol phenylbutyrate | LIQUID;ORAL | 203284-001 | Feb 1, 2013 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | DOSAGE ADJUSTMENT OF A NITROGEN SCAVENGING DRUG IN THE TREATMENT OF A UREA CYCLE DISORDER | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,642,012
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2330892 | ⤷ Subscribe | PA2016041 | Lithuania | ⤷ Subscribe |
European Patent Office | 2330892 | ⤷ Subscribe | CA 2016 00062 | Denmark | ⤷ Subscribe |
European Patent Office | 2330892 | ⤷ Subscribe | 300854 | Netherlands | ⤷ Subscribe |
European Patent Office | 2330892 | ⤷ Subscribe | 122016000107 | Germany | ⤷ Subscribe |
European Patent Office | 2330892 | ⤷ Subscribe | C20160044 00204 | Estonia | ⤷ Subscribe |
European Patent Office | 2330892 | ⤷ Subscribe | CR 2016 00062 | Denmark | ⤷ Subscribe |
European Patent Office | 2330892 | ⤷ Subscribe | 1690060-7 | Sweden | ⤷ Subscribe |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |